Login / Signup

Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study.

L GuiducciCristina VassalleP ParchiSilvia Maffei
Published in: International journal of endocrinology (2019)
The monthly administration of IM NE represents a manageable and effective option, in terms of BMD and bone BM improvement, for the long-term treatment of postmenopausal OP women with gastric intolerance to BPs. This trial is registered with ClinicalTrials.gov Identifier: NCT03699150.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • clinical trial
  • randomized controlled trial
  • study protocol
  • body composition
  • replacement therapy
  • breast cancer risk
  • smoking cessation